Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$370M |
| 2 |
Amazon
AMZN
|
+$349M |
| 3 |
Microsoft
MSFT
|
+$336M |
| 4 |
Meta Platforms (Facebook)
META
|
+$181M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$164M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.07B |
| 2 |
Newmont
NEM
|
+$149M |
| 3 |
Waste Management
WM
|
+$122M |
| 4 |
McDonald's
MCD
|
+$113M |
| 5 |
Eli Lilly
LLY
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.15% |
| 2 | Healthcare | 14.17% |
| 3 | Consumer Discretionary | 13.27% |
| 4 | Communication Services | 11.59% |
| 5 | Industrials | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Peapack-Gladstone Financial
PGC
$810M
| $1.3M | ﹤0.01% |
41,800
+700
| +2% | +$22.6K |
|
2352
Phibro Animal Health
PAHC
$1.36B
| $1.29M | ﹤0.01% |
44,700
-1,700
| -4% | -$46K |
|
2353
Winmark
WINA
$1.28B
| $1.29M | ﹤0.01% |
6,700
| – | – |
|
|
UBA
2354
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $1.29M | ﹤0.01% |
66,336
-1,900
| -3% | -$35.1K |
|
2355
First Mid Bancshares
FMBH
$1.37B
| $1.28M | ﹤0.01% |
31,700
-2,300
| -7% | -$99.4K |
|
|
CMRX
2356
DELISTED
Chimerix, Inc.
CMRX
| $1.28M | ﹤0.01% |
+160,500
| New | +$1.33M |
|
2357
Rush Street Interactive
RSI
$2.85B
| $1.28M | ﹤0.01% |
+104,500
| New | +$1.4M |
|
2358
Spruce Power Holding Corp
SPRU
$39.1M
| $1.28M | ﹤0.01% |
+19,163
| New | +$1.13M |
|
2359
Ducommun
DCO
$3.05B
| $1.27M | ﹤0.01% |
23,300
-1,800
| -7% | -$102K |
|
|
SPPI
2360
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $1.27M | ﹤0.01% |
338,900
+9,400
| +3% | +$32.7K |
|
|
CLVS
2361
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.27M | ﹤0.01% |
218,900
+27,200
| +14% | +$159K |
|
2362
Peoples Bancorp
PEBO
$1.47B
| $1.27M | ﹤0.01% |
42,800
| – | – |
|
2363
Vertex
VERX
$1.94B
| $1.26M | ﹤0.01% |
57,600
+1,800
| +3% | +$36.6K |
|
|
PAE
2364
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $1.26M | ﹤0.01% |
142,000
-3,700
| -3% | -$31.8K |
|
|
ORLA
2365
DELISTED
Orla Mining
ORLA
| $1.26M | ﹤0.01% |
305,100
-10,600
| -3% | -$43.9K |
|
|
TSC
2366
DELISTED
TriState Capital Holdings, Inc.
TSC
| $1.26M | ﹤0.01% |
61,938
+7,400
| +14% | +$169K |
|
2367
Precision BioSciences
DTIL
$208M
| $1.26M | ﹤0.01% |
3,360
+600
| +22% | +$180K |
|
|
CTT
2368
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $1.26M | ﹤0.01% |
107,518
-3,900
| -4% | -$45.3K |
|
|
MSGN
2369
DELISTED
MSG Networks Inc.
MSGN
| $1.26M | ﹤0.01% |
86,200
-3,200
| -4% | -$49.8K |
|
|
TVRD
2370
Tvardi Therapeutics
TVRD
$22.4M
| $1.26M | ﹤0.01% |
2,444
-562
| -19% | -$356K |
|
2371
Byline Bancorp
BY
$1.77B
| $1.25M | ﹤0.01% |
55,300
-2,000
| -3% | -$44.8K |
|
|
VBIV
2372
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $1.25M | ﹤0.01% |
12,450
-457
| -4% | -$44.5K |
|
|
CPRX
2373
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.25M | ﹤0.01% |
217,400
-7,600
| -3% | -$39.2K |
|
|
DX
2374
Dynex Capital
DX
$3.22B
| $1.25M | ﹤0.01% |
66,933
-1,700
| -2% | -$33.3K |
|
2375
Alaunos Therapeutics
TCRT
$4.79M
| $1.25M | ﹤0.01% |
3,149
-115
| -4% | -$53.7K |
|
Similar funds
Swiss National Bank's Q2 2021 Portfolio in Review
As of Q2 2021, Swiss National Bank held 2,687 positions worth $162B, up 8.1% from $150B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Swiss National Bank's Q2 2021 filing shows 205 new, 908 increased, 1,482 reduced and 45 closed positions. Its largest new stake was Lyft: 1,044,300 shares worth $63.2M. The largest sale was Alibaba, an estimated $1.07B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2021 buy was Lyft: 1,044,300 shares worth $63.2M.
- Swiss National Bank added most to Apple in Q2 2021, an estimated $370M increase.
- Swiss National Bank's biggest Q2 2021 reduction was Newmont, cutting an estimated $149M.
- Swiss National Bank fully exited Alibaba in Q2 2021, selling an estimated $1.07B.
- Swiss National Bank's ten largest holdings make up 25% of its $162B portfolio in Q2 2021.
- Swiss National Bank opened 205 new positions and closed 45 in Q2 2021.
- Swiss National Bank's portfolio value rose 8.1% quarter-over-quarter to $162B.
Based on Swiss National Bank's 13F filing for Q2 2021, filed 6 Aug 2021.